Related Experiment Video
Updated: May 5, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock
Thomas Vogl1, Klaus Tenbrock, Stephan Ludwig
1Institute of Experimental Dermatology, University of Münster, D-48129 Münster, Germany.
Abstract:
To identify new components that regulate the inflammatory cascade during sepsis, we characterized the functions of myeloid-related protein-8 (Mrp8, S100A8) and myeloid-related protein-14 (Mrp14, S100A9), two abundant cytoplasmic proteins of phagocytes. We now demonstrate that mice lacking Mrp8-Mrp14 complexes are protected from endotoxin-induced lethal shock and Escherichia coli-induced abdominal sepsis. Both proteins are released during activation of phagocytes, and Mrp8-Mrp14 complexes amplify the endotoxin-triggered inflammatory responses of phagocytes. Mrp8 is the active component that induces intracellular translocation of myeloid differentiation primary response protein 88 and activation of interleukin-1 receptor-associated kinase-1 and nuclear factor-kappaB, resulting in elevated expression of tumor necrosis factor-alpha (TNF-alpha). Using phagocytes expressing a nonfunctional Toll-like receptor 4 (TLR4), HEK293 cells transfected with TLR4, CD14 and MD2, and by surface plasmon resonance studies in vitro, we demonstrate that Mrp8 specifically interacts with the TLR4-MD2 complex, thus representing an endogenous ligand of TLR4. Therefore Mrp8-Mrp14 complexes are new inflammatory components that amplify phagocyte activation during sepsis upstream of TNFalpha-dependent effects.
Insights
Myeloid-related proteins (Mrp8/S100A8 and Mrp14/S100A9) amplify sepsis inflammation. Mice lacking these proteins are protected from lethal shock, revealing their role as endogenous TLR4 ligands.
Area of Science:
- Immunology
- Molecular Biology
- Sepsis Pathophysiology
Background:
- Sepsis involves a complex inflammatory cascade.
- Phagocyte activation is central to sepsis pathogenesis.
- Myeloid-related proteins Mrp8 (S100A8) and Mrp14 (S100A9) are abundant in phagocytes.
Purpose of the Study:
- To investigate the role of Mrp8-Mrp14 complexes in sepsis.
- To identify novel regulators of the inflammatory cascade during sepsis.
- To elucidate the mechanism by which Mrp8-Mrp14 complexes modulate inflammation.
Main Methods:
- Genetic knockout mouse models (Mrp8-Mrp14 deficient).
- Induction of sepsis using endotoxin and Escherichia coli.
- Cellular assays with phagocytes and HEK293 cells.
- Biochemical studies including surface plasmon resonance.
Main Results:
- Mice lacking Mrp8-Mrp14 complexes showed protection against lethal endotoxin shock and E. coli sepsis.
- Mrp8-Mrp14 complexes are released upon phagocyte activation and amplify inflammatory responses.
- Mrp8 acts as an endogenous ligand, directly interacting with the Toll-like receptor 4 (TLR4)-MD2 complex.
- This interaction leads to downstream signaling, including activation of NF-kappaB and increased TNF-alpha production.
Conclusions:
- Mrp8-Mrp14 complexes are critical amplifiers of phagocyte activation in sepsis.
- Mrp8 functions upstream of TNF-alpha, acting as an endogenous TLR4 ligand.
- Targeting Mrp8-Mrp14 complexes represents a potential therapeutic strategy for sepsis.
More Related Videos
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
07:55A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
Published on: January 7, 2020
Related Concept Videos
The Extrinsic Apoptotic Pathway
MAPK Signaling Cascades
Formation of Lipopolysaccharides
Stringent Response in E. coli
Bacterial Toxins
Clinical Significance of Antibiotic Resistance